Journal article
Use of irinotecan combined with 5-fluorouracil and leucovorin as first-line therapy for metastatic colorectal cancer
Abstract
Question What is the role of irinotecan combined with 5-fluorouracil and leucovorin as first-line systemic therapy in the management of metastatic colorectal cancer? Perspectives Evidence was selected and reviewed by two members of the Gastrointestinal Cancer Disease Site Group (DSG) of the Cancer Care Ontario Practice Guidelines Initiative and by methodologists. The present practice guideline has been reviewed and approved by the …
Authors
Jonker D; Earle C; Kocha W; Moore M; Maroun J; Zuraw L; Agboola O; Cummings B; DeNardi FG; Figueredo A
Journal
Current Oncology, Vol. 8, No. 2, pp. 60–68
Publication Date
January 1, 2001